Samenvatting
BACKGROUND: Serum free thyroxine (FT4) testing in pregnancy is known to be challenging for immunoassays (IAs). We verified the reliability of FT4 results by 3 commercial IAs throughout pregnancy, by comparison of the pattern to that obtained with an equilibrium dialysis isotope dilution-mass spectrometry (ED ID-MS) candidate reference measurement procedure.
METHODS: Pregnant females (107) and age-matched non-pregnant controls (26) were enrolled. The IAs tested were those performed on the Cobas 6000 (Roche Diagnostics), ARCHITECT i2000SR (Abbott Diagnostics) and Immulite 2000 (Siemens Healthcare) platforms.
RESULTS: Compared to the controls (mean FT4: 18.2pmol/L), ED ID-MS gave in the late first trimester pregnancy an 8.8% lower (p
CONCLUSION: We proved that IAs may give a FT4 pattern during pregnancy similar to that obtained by ED ID-MS.
METHODS: Pregnant females (107) and age-matched non-pregnant controls (26) were enrolled. The IAs tested were those performed on the Cobas 6000 (Roche Diagnostics), ARCHITECT i2000SR (Abbott Diagnostics) and Immulite 2000 (Siemens Healthcare) platforms.
RESULTS: Compared to the controls (mean FT4: 18.2pmol/L), ED ID-MS gave in the late first trimester pregnancy an 8.8% lower (p
CONCLUSION: We proved that IAs may give a FT4 pattern during pregnancy similar to that obtained by ED ID-MS.
Originele taal-2 | English |
---|---|
Pagina's (van-tot) | 1348-1353 |
Aantal pagina's | 6 |
Tijdschrift | Clin Chim Acta |
Volume | 411 |
Nummer van het tijdschrift | September |
Status | Published - sep 2010 |